Menu
Back to Journals » Clinical Ophthalmology » Volume 4
Enucleation following treatment with intravenous pentamidine for Acanthamoeba sclerokeratitis
Authors Kuennen R, Harder-Smith, Mauger T, Craig E
Published 30 September 2010 Volume 2010:4 Pages 1145—1149
DOI https://doi.org/10.2147/OPTH.S13831
Review by Single anonymous peer review
Peer reviewer comments 2
Rebecca A Kuennen, Reynell Harder Smith, Thomas F Mauger, Elson Craig
Department of Ophthalmology, The Ohio State University, Columbus, Ohio, USA
Purpose: To describe the course and outcome of treatment of advanced Acanthamoeba sclerokeratitis with intravenous pentamidine.
Methods: A case of advanced Acanthamoeba sclerokeratitis was resistant to conventional therapy and was treated with intravenous pentamidine. The eye was later removed due to incapacitating pain.
Results: The eye showed Acanthamoeba organisms within the cornea and evidence of acute and chronic inflammation throughout the remainder of the eye. The patient has survived without orbital recurrence for 2 years.
Conclusions: This case demonstrates late inflammation with active Acanthameoba keratitis following systemic pentamidine therapy.
Keywords: keratitis, scleritis
© 2010 The Author(s). This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution - Non Commercial (unported, v3.0) License.
By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms.